CLINICAL_TRIALS
trial_result
· 2017-08-04
Clinical Trial Update: Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients. [Phase 1]
Summary
A Phase 1 single-dose study of GW685698X magnesium stearate in asthmatic patients has been completed, sponsored by GlaxoSmithKline.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED